Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q1 2023 · 10-Q
Revenue$34.38M$34.38M+9.9% vs Q1 2022 Net Income-$645.00K-$645.00KN/M vs Q1 2022 EPS Diluted$0.00$0.00−100.0% vs Q1 2022 Gross Profit$15,388,000−9.4% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Operating Cash Flow-$4,499,000N/M Free Cash Flowderived-$7,551,000N/M Margins · derivedGross margin44.8%−9.5 pt vs Q1 2022
Operating margin14.9%−7.6 pt vs Q1 2022
Net margin-1.9%−15.3 pt vs Q1 2022
ended Mar 31, 2023 · filed May 9, 2023 · 39 d after period end